Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Acrylamide: Bis-Acrylamide 29:1 (40% Solution/Electrophoresis), Fisher BioReagents

Catalog No. BP1408-1


Order in Bulk

Request bulk or custom formats

Explore all special offers
Add to Cart

Description

Description

PP Bottle; 1 L

This Acrylamide Solution is premixed for 3.3% cross-linking and is suitable for DNA sequencing and separation of proteins.
Specifications

Specifications

Acrylamide: Bis-Acrylamide 29:1
40% Solution
10μmhos max.
Colorless
Polypropylene Bottle
C3H5NO
HRPVXLWXLXDGHG-UHFFFAOYSA-N
prop-2-enamide
6579
Electrophoresis
Liquid
79-06-1, 110-26-9, 7732-18-5
1.035 g/mL
1 L
DNase-, RNase- and Protease-Free
MFCD00008032
NC(=O)C=C
71.08
CHEBI:28619
Product Suggestions

Product Suggestions

Videos
Safety and Handling

Safety and Handling

WARNING!

Emergency Overview
WARNING! Suspect cancer hazard. May cause heritable genetic damage. Toxic if swallowed. Harmful if absorbed through skin or if inhaled. Irritating to eyes and skin. May cause irritation of respiratory tract. May cause an allergic skin reaction. Danger of serious damage to health by prolonged exposure. Possible risk of impaired fertility. Hazardous polymerization may occur. Use personal protective equipment. Keep away from open flames, hot surfaces and sources of ignition. Keep away from open flames, hot surfaces and sources of ignition. Use only under a chemical fume hood.

NFPA

Health: 3
Flammability: 1
Instability: 2

Recommended Storage : 4°C

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.